Onychomycosis: Treatment and Prevention of Recurrence

Shari R Lipner, Richard K Scher

J Am Acad Dermatol. 2019 Apr;80(4):853-867.

PMID: 29959962

Abstract:

Onychomycosis is a fungal nail infection caused by dermatophytes, nondermatophytes, and yeast, and is the most common nail disorder seen in clinical practice. It is an important problem because it may cause local pain, paresthesias, difficulties performing activities of daily living, and impair social interactions. The epidemiology, risk factors, and clinical presentation and diagnosis of onychomycosis were discussed in the first article in this continuing medical education series. In this article, we review the prognosis and response to onychomycosis treatment, medications for onychomycosis that have been approved by the US Food and Drug Administration, and off-label therapies and devices. Methods to prevent onychomycosis recurrences and emerging therapies are also described.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP174671466	Tavaborole		174671-46-6	Price